Astro-Med, Inc. 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Astro-Med, Inc. for the period ended May 2, 1998. The company operates in three primary product groups: Test and Measurement (T&M), QuickLabel Systems (QLS), and Grass Instruments. The filing covers the first fiscal quarter of 1998.
Key Financial Metrics
| Metric | Q1 1998 | Q1 1997 |
|---|---|---|
| Net Sales | $10,056,440 | $11,706,507 |
| Gross Profit | $3,875,607 | $4,503,911 |
| Gross Margin | 39% | 39% |
| Operating Income (Loss) | $(389,992) | $655,485 |
| Net Income (Loss) | $(103,808) | $578,372 |
| Diluted EPS | $(0.02) | $0.12 |
| Cash from Operations | $358,042 | $1,288,310 |
| Cash and Equivalents (End) | $5,504,771 | $7,157,818 |
| Total Debt (Current + Long-Term) | $349,567 | N/A |
| Current Ratio | 5.5:1 | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 14% year-over-year to $10.06 million. The Test and Measurement (T&M) group drove this decline with a 29% drop in sales due to aerospace/defense consolidation and Asian market dysfunction.
- Profitability Shift: The company reported a net loss of $103,808 compared to a net income of $578,372 in the prior year. Operating expenses increased 11% due to personnel additions in sales, R&D, and IT, as well as marketing costs.
- Product Mix: While T&M declined, QuickLabel Systems (QLS) and Grass Instruments grew by 1% and 5%, respectively. Despite the shift in product mix, the gross margin remained stable at 39%.
- Cash Flow: Net cash provided by operating activities fell significantly to $358,042 from $1.29 million, largely due to the net loss and increased inventory levels ($376,027 outflow).
Outlook, Risks, and Management Commentary
Management notes the company is weathering negative market effects, including a stronger dollar in Europe and consolidation in the defense sector. Capital expenditures of $184,000 were made for IT and manufacturing test equipment. The company repurchased 28,000 shares of common stock and paid a quarterly dividend of $0.04 per share.
Risks and Contingencies: Forward-looking statements are subject to risks including general economic conditions, competitive pricing pressures, inventory risks due to demand shifts, component shortages, and the timely development of new products.
Investor Verification Checklist
- Verify the sustainability of the 39% gross margin given the significant decline in the high-volume T&M segment.
- Monitor the trajectory of operating expenses, which rose 11% while revenue fell, to assess future profitability.
- Review the impact of the stronger dollar on European sales performance in subsequent quarters.
- Confirm the status of inventory levels, which increased by $376,027 during the quarter, against current demand forecasts.
- Check the remaining authorization for the stock repurchase plan (373,676 shares remaining).